Evaluation of the Prophylactic Use of Letermovir in Kidney Transplant Recipients at Risk of Cytomegalovirus Infection
Conditions: CMV Infection Interventions: Drug: Letermovir 480 MG; Drug: Ganciclovir Sponsors: Hospital do Rim e Hipertens ão Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cytomegalovirus | Hospitals | Kidney Transplant | Kidney Transplantation | Research | Transplant Surgery | Transplants | Urology & Nephrology